Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 4 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 28% ± 11% | |
glutamatergic neuron | 3 studies | 34% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2311.05 | 652 / 653 | 83% | 7.82 | 503 / 605 |
lung | 98% | 2351.73 | 565 / 578 | 67% | 3.94 | 775 / 1155 |
uterus | 79% | 908.65 | 134 / 170 | 54% | 2.10 | 249 / 459 |
stomach | 72% | 579.41 | 259 / 359 | 37% | 0.83 | 105 / 286 |
brain | 83% | 841.57 | 2194 / 2642 | 19% | 0.38 | 131 / 705 |
pancreas | 50% | 170.08 | 165 / 328 | 42% | 0.72 | 75 / 178 |
skin | 79% | 1844.60 | 1426 / 1809 | 13% | 0.31 | 60 / 472 |
intestine | 66% | 841.79 | 633 / 966 | 25% | 0.81 | 133 / 527 |
ovary | 37% | 170.27 | 66 / 180 | 48% | 0.90 | 205 / 430 |
bladder | 52% | 339.10 | 11 / 21 | 26% | 0.78 | 129 / 504 |
kidney | 38% | 160.71 | 34 / 89 | 23% | 0.57 | 205 / 901 |
esophagus | 10% | 37.31 | 151 / 1445 | 49% | 1.43 | 90 / 183 |
breast | 31% | 121.60 | 142 / 459 | 22% | 0.61 | 242 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 44% | 1.22 | 20 / 45 |
blood vessel | 18% | 62.34 | 237 / 1335 | 0% | 0 | 0 / 0 |
muscle | 16% | 56.65 | 127 / 803 | 0% | 0 | 0 / 0 |
heart | 15% | 41.11 | 128 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 14% | 0.33 | 57 / 406 |
prostate | 5% | 14.28 | 13 / 245 | 4% | 0.06 | 20 / 502 |
adrenal gland | 2% | 13.60 | 5 / 258 | 5% | 0.09 | 11 / 230 |
adipose | 3% | 10.27 | 32 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0061817 | Biological process | endoplasmic reticulum-plasma membrane tethering |
GO_0006869 | Biological process | lipid transport |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0044232 | Cellular component | organelle membrane contact site |
GO_0140268 | Cellular component | endoplasmic reticulum-plasma membrane contact site |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008429 | Molecular function | phosphatidylethanolamine binding |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
Gene name | ESYT3 |
Protein name | Extended synaptotagmin 3 Extended synaptotagmin-3 (E-Syt3) (Chr3Syt) |
Synonyms | FAM62C |
Description | FUNCTION: Binds glycerophospholipids in a barrel-like domain and may play a role in cellular lipid transport (By similarity). Tethers the endoplasmic reticulum to the cell membrane and promotes the formation of appositions between the endoplasmic reticulum and the cell membrane. . |
Accessions | A0FGR9 ENST00000389567.9 [A0FGR9-1] ENST00000490835.5 [A0FGR9-2] ENST00000289135.4 H7BXJ6 |